We know they got paid for the first order in August, so that will be in the reported quarter coming in early December, plus they've made small sales from the www.oximunol.com temporary site.  Cash position should be good too - the financing won't be included in the statements, but recent grants and the payment will be.  The second Teva order is the next key milestone I'm expecting...